Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)
Clinical trial NCT05603013 · UNKNOWN
Trial details
- NCT number
- NCT05603013
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-30
- Primary completion
- 2024-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.